Difficulty: Medium
Average Score: 86%
Practice
Bleomycin is used in most effective drug combination regimen for the chemotherapy of testicular carcinoma. Which one of the following statements about the drug is accurate?
Correct answer
D
Rationale
In this scenario, option D, "Pulmonary infiltrates and fibrosis may occur," is the correct answer. Bleomycin is known to cause pulmonary toxicity, which can manifest as pulmonary infiltrates and fibrosis. This adverse effect is a significant consideration in the use of this drug and can be dose-limiting in some cases.
Option A, "Acts mainly in the M phase of the cell cycle," is incorrect. Bleomycin exerts its cytotoxic effects by causing DNA strand breaks, primarily in the G2 phase of the cell cycle, not specifically in the M phase.
Option B, "Derived from the bark of yew trees," is also incorrect. Bleomycin is not derived from yew trees; it is a natural product produced by the bacterium Streptomyces verticillus.
Option C, "Myelosuppression is dose-limiting," is incorrect. While myelosuppression can occur with some chemotherapy drugs, it is not the primary dose-limiting toxicity of bleomycin.
Educationally, understanding the side effects and mechanisms of action of chemotherapeutic agents is crucial for healthcare professionals involved in cancer treatment. Knowledge of specific drug toxicities, like pulmonary toxicity with bleomycin, is essential for patient care, monitoring, and management to ensure optimal outcomes for individuals undergoing chemotherapy.
Option A, "Acts mainly in the M phase of the cell cycle," is incorrect. Bleomycin exerts its cytotoxic effects by causing DNA strand breaks, primarily in the G2 phase of the cell cycle, not specifically in the M phase.
Option B, "Derived from the bark of yew trees," is also incorrect. Bleomycin is not derived from yew trees; it is a natural product produced by the bacterium Streptomyces verticillus.
Option C, "Myelosuppression is dose-limiting," is incorrect. While myelosuppression can occur with some chemotherapy drugs, it is not the primary dose-limiting toxicity of bleomycin.
Educationally, understanding the side effects and mechanisms of action of chemotherapeutic agents is crucial for healthcare professionals involved in cancer treatment. Knowledge of specific drug toxicities, like pulmonary toxicity with bleomycin, is essential for patient care, monitoring, and management to ensure optimal outcomes for individuals undergoing chemotherapy.